TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion
NCT01654445
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Stroke
Interventions
DRUG:
Tenecteplase
Sponsor
University of Calgary
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]